FGF21 and hyperlipidemia: Treatment with fibroblast growth factor 21 (FGF21), an important regulator of metabolism and energy homeostasis significantly decreased ceramide accumulation in hepatocytes of obese mice through increasing the expression of adiponectin, which leads to the restoration of euglycemia and reduced hyperlipidemia.